Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy: Need for Debate on the Optimized Treatment Strategy for Node-positive Upper Tract Urothelial Carcinoma

Keisuke Shigeta; Kazuhiro Matsumoto; Mototsugu Oya

doi:10.1016/j.eururo.2021.10.008

Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy: Need for Debate on the Optimized Treatment Strategy for Node-positive Upper Tract Urothelial Carcinoma

Keisuke Shigeta, Kazuhiro Matsumoto, Mototsugu Oya

泌尿器科学

研究成果: Letter › 査読

本文言語	English
ページ（範囲）	e20-e21
ジャーナル	European Urology
巻	81
号	1
DOI	https://doi.org/10.1016/j.eururo.2021.10.008
出版ステータス	Published - 2022 1月

ASJC Scopus subject areas

泌尿器学

文献へのアクセス

10.1016/j.eururo.2021.10.008

他のファイルとリンク

引用スタイル

Shigeta, K., Matsumoto, K., & Oya, M. (2022). Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy: Need for Debate on the Optimized Treatment Strategy for Node-positive Upper Tract Urothelial Carcinoma. European Urology, 81(1), e20-e21. https://doi.org/10.1016/j.eururo.2021.10.008

Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy: Need for Debate on the Optimized Treatment Strategy for Node-positive Upper Tract Urothelial Carcinoma. / Shigeta, Keisuke; Matsumoto, Kazuhiro ; Oya, Mototsugu.
In: European Urology, Vol. 81, No. 1, 01.2022, p. e20-e21.

研究成果: Letter › 査読

Shigeta, K, Matsumoto, K & Oya, M 2022, 'Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy: Need for Debate on the Optimized Treatment Strategy for Node-positive Upper Tract Urothelial Carcinoma', European Urology, vol. 81, no. 1, pp. e20-e21. https://doi.org/10.1016/j.eururo.2021.10.008

Shigeta K, Matsumoto K , Oya M. Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy: Need for Debate on the Optimized Treatment Strategy for Node-positive Upper Tract Urothelial Carcinoma. European Urology. 2022 1月;81(1):e20-e21. doi: 10.1016/j.eururo.2021.10.008

Shigeta, Keisuke ; Matsumoto, Kazuhiro ; Oya, Mototsugu. / Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re : Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy: Need for Debate on the Optimized Treatment Strategy for Node-positive Upper Tract Urothelial Carcinoma. In: European Urology. 2022 ; Vol. 81, No. 1. pp. e20-e21.

@article{80700e54d2b14616a2e7c2a80eb6ddd0,

title = "Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy: Need for Debate on the Optimized Treatment Strategy for Node-positive Upper Tract Urothelial Carcinoma",

author = "Keisuke Shigeta and Kazuhiro Matsumoto and Mototsugu Oya",

year = "2022",

month = jan,

doi = "10.1016/j.eururo.2021.10.008",

language = "English",

volume = "81",

pages = "e20--e21",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re

T2 - Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy: Need for Debate on the Optimized Treatment Strategy for Node-positive Upper Tract Urothelial Carcinoma

AU - Shigeta, Keisuke

AU - Matsumoto, Kazuhiro

AU - Oya, Mototsugu

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85121205387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85121205387&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2021.10.008

DO - 10.1016/j.eururo.2021.10.008

M3 - Letter

C2 - 34716047

AN - SCOPUS:85121205387

SN - 0302-2838

VL - 81

SP - e20-e21

JO - European Urology

JF - European Urology

IS - 1

ER -